Menu
Washingtoner
  • Home
  • Financial
  • Technology
  • Non-profit
  • Boeing
  • Business
  • Services
  • Daryl Guberman
  • Aerospace
Washingtoner

Broadmark Realty Capital Announces $200 Million At-the-Market Equity Offering Program
Washingtoner/10100879

Trending...
  • Notice: Hrm Queen Laurence I Assumes Crown Control & $317q Fund. 3bn Unopoly Shares Settled. Requisition Of Buckingham Palace & Windsor Castle Final
  • Yoga Retreats, Ecstatic Dance & Spiritual App launched
  • 13 Full Moons of Black Dandelion Convergent Voice™ An Integration of Literacy & Wellness Symposium
SEATTLE--(BUSINESS WIRE)--Broadmark Realty Capital Inc. (NYSE: BRMK) (the "Company"), an internally managed secured real estate finance company, today announced that it has filed a prospectus supplement with the Securities and Exchange Commission ("SEC") under which it may offer and sell shares of its common stock (the "Shares") having an aggregate offering price of up to $200 million from time to time through an "at-the-market" equity offering program (the "ATM Program"). The Company currently intends to use the net proceeds from sales of Shares under the ATM Program for general corporate purposes, including to fund the Company's lending activities. The timing of any sales will depend on a variety of factors to be determined by the Company.

The Shares will be offered through J.P. Morgan Securities LLC, Barclays Capital Inc., B. Riley Securities, Inc., JMP Securities LLC and Raymond James & Associates, Inc., as sales agents (the "Agents"). The Agents may sell Shares by any method deemed to be an "at-the-market offering" as defined in Rule 415 of the Securities Act of 1933, as amended, including sales by means of ordinary brokers' transactions on the New York Stock Exchange or sales made to or through a market maker other than on an exchange, in block transactions or by any other method permitted by law, at prices related to the prevailing market prices or at negotiated prices.

More on Washingtoner
  • A Stolen MacBook Leads Spokane Police To Discover Multiple Stolen Items And A Burglary Arrest
  • Benchmark International Facilitated the Trans BT Matheson Painting and an Undisclosed Buyer
  • Training Lofts Launches $1,099 Unlimited Training Membership Featuring Semi-Private Coaching, Nutrition Support, and Recovery Services
  • American Properties Realty, Inc. Leadership Attends NAHB International Builders' Show in Florida
  • $317M Revenue and a Clear Path to $1B: $IQST is Positioned for a Major Profitability Inflection

The Shares will be offered under the Company's shelf registration statement on Form S-3 (File No.: 333-251075) filed with the SEC, which registration statement is effective. A prospectus supplement and accompanying prospectus describing the terms of the offering have been filed with the SEC, copies of which may be obtained by visiting the SEC's website at www.sec.gov or from: J.P. Morgan Securities, LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, Attention: Prospectus Group or by calling toll free at (866) 803-9204; Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, by telephone (888) 603-5847, or by email at Barclaysprospectus@broadridge.com; B. Riley Securities, Inc., Attention: Prospectus Department, 1300 North 17th Street, Suite 1300, Arlington, Virginia 2209, by telephone at (703) 312-9580, or by email at prospectuses@brileyfin.com; JMP Securities LLC, 600 Montgomery Street, Suite 1100, San Francisco, California 94111, Attention: Prospectus Department, by telephone at (415) 835-8985, or by e-mail at sundicate@jmpsecurities.com; or Raymond James & Associates, Inc., Attention: Equity Syndicate, 880 Carillon Parkway, St. Petersburg, FL 33716, by telephone at (800) 248-8862, or by email at prospectus@raymondjames.com.

More on Washingtoner
  • ASI Hosts 2026 Executive Business Summit for Global Partner Community
  • ANAB's False 'Underwriter' Claim Taints Global AS9100 Certificates for 10 Major Aircraft Makers and Their Supply Chains
  • Pastor Saeed Abedini Releases THE TRUTH – Volume 1, A Deeply Personal Story of Faith, Struggle, and Redemption
  • New Book Warring From the Standpoint of the Throne Room Calls Believers to Pray From Victory
  • City of Spokane Prepared For Forecasted Winds

This press release is for informational purposes only and is not an offer to sell or the solicitation of an offer to buy any Shares of the Company, which is made only by means of a prospectus supplement and related prospectus. There will be no sale of Shares in any jurisdiction in which the offer, solicitation of an offer to buy or sale would be unlawful.

About Broadmark Realty Capital

Broadmark Realty Capital Inc. (NYSE: BRMK) is an internally managed commercial real estate finance company that offers short-term, first deed of trust loans secured by real estate to fund the acquisition, renovation, rehabilitation or development of residential or commercial properties. Broadmark Realty Capital manages and services its loan portfolio across a variety of market conditions and economic cycles.

Forward Looking Statements

Certain statements made herein are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "may", "should", "would", "plan", "intend", "anticipate", "believe", "estimate", "predict", "potential", "seem", "seek", "continue", "future", "will", "expect", "outlook" or other similar words, phrases or expressions. These statements are based on the current expectations and are not predictions of actual performance. In addition, actual results are subject to other risks and uncertainties that relate more broadly to the Company's overall business, including those more fully described in the Company's filings with the SEC. Forward-looking statements are not guarantees of performance, and speak only as of the date made, and the Company undertakes no obligation to update or revise any forward-looking statements except as required by law.
Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Energywise Solutions and Pickleball Pros Partner to Bring More Energy and Visibility to Pickleball Clubs
  • Buildout Launches CRM, Completing the Industry's First AI-Powered End-to-End Deal Engine for CRE
  • The Franchise King® Releases Free Guide for Nervous Buyers
  • The Unsweetened Tooth Declares the End of Sugar‑Spiked Cookies
  • Kanguro Insurance Taps Paylode to Launch Best-in-Class Pet and Renters Insurance Rewards Experience
  • CCHR: CIA Mind-Control Files Raise Urgent Questions as Millions Take Psychotropic Drugs
  • NRx Pharmaceuticals Launches Breakthrough One-Day Treatment Clinic in Florida as FDA Pathway and Clinical Data Strengthen Growth Outlook; $NRXP
  • Revenue Optics Launches Talent Infrastructure Platform for SaaS Revenue Hiring and Appoints Sabz Kaur to Lead Growth
  • Building a Multi-Domain Autonomous Systems Platform at the Intersection of AI, Defense and Infrastructure: VisionWave Holdings (N A S D A Q: VWAV)
  • Bent Danholm Named "Top Luxury Real Estate Leader" in Modern Luxury Miami
  • Window Sticker Lookup By VIN Launches Free Direct OEM Monroney Label Lookups
  • Author Ken Mora to Celebrate New Caravaggio Book Debut with Special Event at Palazzo Venezia Naples
  • Matthew Sisneros Releases Raw and Unfiltered Memoir: The Devil Lost Another One — A Powerful Story of Crime, Consequence, and Redemption
  • From Life to Light: Jess L. Martinez Shares a Soulful Poetry Collection That Explores What It Means to Be Human
  • Lawsuit Filed Against Boeing Over Defective Seat Switch on Boeing 787
  • Quadcode Acquires Significant Stake in Game 7, LLC - The Parent Company for FPFX Tech and PropAccount.com
  • Danholm Collection Announces Sale of 16689 Broadwater Ave in Winter Garden, Highlighting Strong Performance in Twinwaters Community
  • Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA
  • 46th International Symposium On Forecasting – Dates, Venue And Speakers Announced
  • Phoenix Rebellion Therapy Celebrates 10 Years Helping Utahns Overcome Trauma as Utah Faces Nation's 2nd-Highest Rate of Mental Health Challenges
_catLbl0 _catLbl1

Popular on Washingtoner

  • Still Using Ice? FrostSkin Reinvents Hydration - 117
  • Male In Custody After North Spokane Drive By Shooting - 103
  • Spokane: 2026 Safe Streets For All (Traffic Calming) Updates
  • Tacoma: Applicants Sought for the Public Utility Board
  • Cold. Clean. Anywhere. Meet FrostSkin
  • Ice Melts. Infrastructure Fails. What Happens to Clean Water?
  • Spokane: Water Wise Wednesday Workshops Begin March 4
  • Primeindexer Google indexing platform launched by SEO Danmark APS
  • Amicly Launches as a Safety-First Social App Designed to Help People Build Real, Meaningful Friendships
  • Angels Of Dirt Premieres on Youtube, Announces Paige Keck Helmet Sponsorship for 2026 Season

Similar on Washingtoner

  • $317M Revenue and a Clear Path to $1B: $IQST is Positioned for a Major Profitability Inflection
  • Scotch Whisky Market Dislocation Creates Compelling Entry Opportunity for Long-Term Investors
  • $6 Million Funding Secured as Retail Expansion, Operational Streamlining, and Asset-Light Strategy Position the Company for Accelerated Growth $SOWG
  • The "Unsexy" Business Quietly Creating 130+ New Entrepreneurs Across America — From Alaska to Puerto Rico
  • Veteran Launches GTG Energy: Nicotine-Free Pouch as Americans Rethink Addiction, Focus, and What Fuels Performance
  • K2 Integrity Enhances Technology Capabilities Through Acquisition of Leviathan Security Group
  • Energywise Solutions and Pickleball Pros Partner to Bring More Energy and Visibility to Pickleball Clubs
  • Buildout Launches CRM, Completing the Industry's First AI-Powered End-to-End Deal Engine for CRE
  • The Franchise King® Releases Free Guide for Nervous Buyers
  • NRx Pharmaceuticals Launches Breakthrough One-Day Treatment Clinic in Florida as FDA Pathway and Clinical Data Strengthen Growth Outlook; $NRXP
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute